Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing–Remitting Multiple Sclerosis
Titel:
Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing–Remitting Multiple Sclerosis
Auteur:
Orefice, Nicola S. Alhouayek, Mireille Carotenuto, Antonio Montella, Silvana Barbato, Franscesco Comelli, Albert Calignano, Antonio Muccioli, Giulio G. Orefice, Giuseppe
Verschenen in:
Neurotherapeutics
Paginering:
Jaargang 13 () nr. 2 pagina's 428-438
Jaar:
2016
Inhoud:
Uitgever:
The American Society for Experimental NeuroTherapeutics, Inc.